{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:59:35Z","timestamp":1783699175689,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T00:00:00Z","timestamp":1618704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.alit.2021.04.003","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T03:51:54Z","timestamp":1619149914000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Allergy to COVID-19 vaccines: A current update"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-8140","authenticated-orcid":false,"given":"Beatriz","family":"Cabanillas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalija","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2021.04.003_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/pai.12102","article-title":"Allergic reactions to vaccines","volume":"24","author":"Wood","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.alit.2021.04.003_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/pai.12762","article-title":"Vaccination and allergy: EAACI position paper, practical aspects","volume":"28","author":"Nilsson","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.alit.2021.04.003_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.04.003_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.04.003_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2021.04.003_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.alit.2021.04.003_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020","volume":"70","author":"Administration FDA","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.alit.2021.04.003_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021","volume":"70","author":"Administration FDA","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.alit.2021.04.003_bib9","article-title":"Allergic reactions to the first COVID-19 vaccine: a potential role of Polyethylene glycol?","author":"Cabanillas","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.04.003_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining safety with SARS-CoV-2 vaccines","volume":"384","author":"Castells","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.04.003_bib11","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.alit.2021.04.003_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.alit.2021.04.003_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cea.12760","article-title":"Immediate-type hypersensitivity to polyethylene glycols: a review","volume":"46","author":"Wenande","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2021.04.003_bib14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaip.2018.12.003","article-title":"Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized","volume":"7","author":"Stone","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.04.003_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","article-title":"Polyethylene glycol-induced systemic allergic reactions (anaphylaxis)","volume":"9","author":"Sellaturay","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.04.003_bib16","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaip.2020.11.011","article-title":"Anti-PEG IgE in anaphylaxis associated with polyethylene glycol","volume":"9","author":"Zhou","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.04.003_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/all.14725","article-title":"COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: \u201cCOVID-19 vaccine anaphylaxis: PEG or not?","author":"Cabanillas","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.04.003_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/all.14722","article-title":"COVID-19 vaccine anaphylaxis: PEG or not?","author":"Krantz","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.04.003_bib19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jaip.2019.12.041","article-title":"Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy","volume":"8","author":"Krantz","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.04.003_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/ACI.0000000000000655","article-title":"Immediate hypersensitivity reactions to steroids and steroid containing medications","volume":"20","author":"Rutkowski","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2021.04.003_bib21","first-page":"2715","article-title":"Basics of pharmaceutical emulsions: a review","volume":"5","author":"Khan","year":"2011","journal-title":"Afr J Pharm Pharmacol"},{"key":"10.1016\/j.alit.2021.04.003_bib22","doi-asserted-by":"crossref","first-page":"113126","DOI":"10.1016\/j.jpba.2020.113126","article-title":"Evaluation of a sensitive GC-MS method to detect polysorbate 80 in vaccine preparation","volume":"183","author":"Shende","year":"2020","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.alit.2021.04.003_bib23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.anai.2018.02.018","article-title":"Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate","volume":"120","author":"Perino","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2021.04.003_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.18176\/jiaci.0109","article-title":"Anaphylaxis due to the excipient polysorbate 80","volume":"26","author":"Palacios Casta\u00f1o","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.alit.2021.04.003_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2012.5797","article-title":"Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80","volume":"2012","author":"Badiu","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.alit.2021.04.003_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0536.2006.00990.x","article-title":"Contact sensitivity to octyldodecanol and trometamol in an anti-itch cream","volume":"56","author":"Singh","year":"2007","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.alit.2021.04.003_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2214\/ajr.167.4.8819369","article-title":"Adverse reactions to gadolinium contrast media: a review of 36 cases","volume":"167","author":"Murphy","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.alit.2021.04.003_bib28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1148\/radiology.176.3.879-a","article-title":"Severe anaphylactoid reaction to Gd-DTPA","volume":"176","author":"Lufkin","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.alit.2021.04.003_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaip.2018.08.035","article-title":"Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging","volume":"7","author":"Lukawska","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.04.003_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/all.14774","article-title":"Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines","author":"Borgsteede","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.04.003_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaip.2013.12.001","article-title":"Systemic allergy to EDTA in local anesthetic and radiocontrast media","volume":"2","author":"Russo","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.04.003_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4065\/84.3.268","article-title":"Mechanisms of drug-induced allergy","volume":"84","author":"Schnyder","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.alit.2021.04.003_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.alit.2021.04.003_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/all.14739","article-title":"EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines","author":"Sokolowska","year":"2021","journal-title":"Allergy"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:11:53Z","timestamp":1761156713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893021000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1323893021000459"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2021.04.003","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergy to COVID-19 vaccines: A current update","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2021.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}